Carcinogenesis Advance Access published online on March 25, 2004
Carcinogenesis, doi:10.1093/carcin/bgh144
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CANCER BIOLOGY
1 Laboratory of Cellular and Molecular Biology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224-6825
* Corresponding author. E-mail: me42v{at}nih.gov.
Received 9 December 2003
; revised 5 March 2004
; accepted 7 March 2004
Mutagenic oxidative DNA base damage increases with age in prostatic tissue. Various factors may influence this increase including: increased production of reactive oxygen species, increased susceptibility to oxidative stress, alterations in detoxifying enzyme levels or defects in DNA repair. Using LC/MS and GC/MS, we show increased levels of oxidative DNA base lesions, 8-hydroxyguanine (8-oxoG), 8-oxoadenine (8-oxoA) and 5-hydroxycytosine (5OHC) over the baseline in PC-3 and DU-145 prostate cancer cells following exposure to ionizing radiation and a repair period. Nuclear extracts from PC-3 and DU-145 prostate cancer cell lines are defective in the incision of 8-oxoG, 5OHC and thymine glycol (TG) relative to the non-malignant prostate cell line. Consistent with reduced expression of OGG1 2a, incision of 8-oxoG is reduced in PC-3 and DU-145 mitochondrial extracts. We also show a correlation between severely defective incision of TG and 5OHC and reduced levels of NTH1 in PC-3 mitochondria. The antioxidant enzymes, glutathione peroxidase (GPx), catalase, and superoxide dismutases (SOD1, SOD2), have altered expression patterns in these cancer cell lines. Genetic analysis of the OGG1 gene reveals that both PC-3 and DU-145 cell lines harbor polymorphisms associated with a higher susceptibility to certain cancers. These data suggest that the malignant phenotype in PC-3 and DU-145 cell lines may be associated with defects in base excision repair (BER) and alterations in expression of antioxidant enzymes.
oxidative DNA damage, base excision repair, prostate cancer, reactive oxygen species, mitochondrial DNA, antioxidant enzymes
Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145
2 Department of Chemical and Biochemical Engineering, University of Maryland Baltimore County, Baltimore, MD 21250; Chemical Science and Technology Laboratory, National Institute of Standards and Technology, Gaithersburg, MD 20899
3 Chemical Science and Technology Laboratory, National Institute of Standards and Technology, Gaithersburg, MD 20899
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Waters, S. Shen, H. Xu, S. S. Kengeri, D. M. Cooley, E. C. Chiang, Y. Chen, D. Schlittler, C. Oteham, G. F. Combs Jr., et al. Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1906 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Choi, M. L. Neuhouser, M. Barnett, M. Hudson, A. R. Kristal, M. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone Polymorphisms in Oxidative Stress-Related Genes Are Not Associated with Prostate Cancer Risk in Heavy Smokers Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1115 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bonde, D. Gao, L. Chen, M. Duncan, T. Miyashita, E. Montgomery, J. W. Harmon, and C. Wei Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 74 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Sokhansanj and D. M. Wilson III Estimating the effect of human base excision repair protein variants on the repair of oxidative DNA base damage. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1000 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Hill and M. K. Evans Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase Nucleic Acids Res., March 20, 2006; 34(5): 1620 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J.M. Best, J. W. Gillespie, Y. Yi, G. V.R. Chandramouli, M. A. Perlmutter, Y. Gathright, H. S. Erickson, L. Georgevich, M. A. Tangrea, P. H. Duray, et al. Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy Clin. Cancer Res., October 1, 2005; 11(19): 6823 - 6834. [Abstract] [Full Text] [PDF]
|
|